4 clinical trials registered. Interventions under study include other interventions, biologic therapy, drug therapy, and procedural interventions. Pipeline includes 2 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
398 publications have been identified in PubMed for B-cell adult acute lymphocytic leukemia. Kisho has analyzed 304 by research type. Research spans Clinical Trial Publication (27%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (16%).
Gravenmier C (2026). [PMID: 41295979](https://pubmed.ncbi.nlm.nih.gov/41295979/). *Cancer Res Commun*. [Basic Science / Preclinical]
Jacob S (2026). [PMID: 41842713](https://pubmed.ncbi.nlm.nih.gov/41842713/). *Cytopathology*. [Diagnostic / Biomarker]
Mikami T (2026). [PMID: 41579860](https://pubmed.ncbi.nlm.nih.gov/41579860/). *Cell Rep Med*. [Gene Therapy / Novel Therapeutics]
Maqbool S (2026). [PMID: 41725421](https://pubmed.ncbi.nlm.nih.gov/41725421/). *Leuk Lymphoma*. [Epidemiology / Natural History]
Talman M (2026). [PMID: 41574496](https://pubmed.ncbi.nlm.nih.gov/41574496/). *Pediatr Dev Pathol*. [Review / Meta-Analysis]
Seheult JN (2026). [PMID: 40966417](https://pubmed.ncbi.nlm.nih.gov/40966417/). *Blood Adv*. [Gene Therapy / Novel Therapeutics]
Dreyzin A (2026). [PMID: 41190967](https://pubmed.ncbi.nlm.nih.gov/41190967/). *Cytotherapy*. [Clinical Trial Publication]
Goldberg L (2026). [PMID: 41720802](https://pubmed.ncbi.nlm.nih.gov/41720802/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]
Grzywa TM (2026). [PMID: 40855124](https://pubmed.ncbi.nlm.nih.gov/40855124/). *Nat Biomed Eng*. [Basic Science / Preclinical]
Lecornec N (2026). [PMID: 41735483](https://pubmed.ncbi.nlm.nih.gov/41735483/). *Leukemia*. [Clinical Trial Publication]
